Russia Registers 'Allergard' Vaccine for Birch Pollen Allergy
- Published:
- First detected:
Insights by Echo AI
The Russian Ministry of Health has registered the 'Allergard' vaccine for the prevention and treatment of allergic rhinoconjunctivitis caused by birch pollen allergy and associated cross-food allergies. The vaccine, developed by the Institute of Immunology of the Federal Medical and Biological Agency of Russia and Vienna Medical University, uses laboratory-created fragments of birch and apple allergens to trigger a protective immune response. The vaccination course consists of three to five injections administered outside the flowering season.
Source coverage
22
records merged
0
0 unique
16
14 unique
6
5 unique
22 Sources
Минздрав РФ зарегистрировал вакцину для аллергиков Препарат "Аллегард...
Минздрав РФ зарегистрировал вакцину от аллергии на пыльцу березы Минзд...
Минздрав зарегистрировал российскую вакцину от аллергии
Вакцину для аллергиков зарегистрировали в Минздраве РФ. Препарат «Алл...
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
